Global Smart Drug Delivery Systems 麻豆原创 Research Report 2025

Publication ID:

PB504251331

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Smart Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Smart Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smart Drug Delivery Systems.
The Smart Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Smart Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Smart Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott Laboratories
Adherium Ltd.
Amiko Digital Health Limited
Becton, Dickinson and Company
BIOCORP
CeQur Corporation
Cognita Labs
E3D Elcam Drug Delivery Devices
H&T Presspart Manufacturing Ltd.
HCmed Innovations Co., Ltd.
Medtronic plc
Novo Nordisk A/S
Phillips-Medisize
Sonceboz
Segment by Type
Connected Inhalers
Connected Autoinjectors
Connected Pen Injectors
Connected Wearable Injectors
Others
Segment by Application
Hospitals
Clinics
麻豆原创 Care
Ambulatory Care Settings
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Smart Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Smart Drug Delivery Systems 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Connected Inhalers
1.2.3 Connected Autoinjectors
1.2.4 Connected Pen Injectors
1.2.5 Connected Wearable Injectors
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Smart Drug Delivery Systems 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 麻豆原创 Care
1.3.5 Ambulatory Care Settings
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Smart Drug Delivery Systems 麻豆原创 Perspective (2020-2031)
2.2 Global Smart Drug Delivery Systems Growth Trends by Region
2.2.1 Global Smart Drug Delivery Systems 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Smart Drug Delivery Systems Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Smart Drug Delivery Systems Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Smart Drug Delivery Systems 麻豆原创 Dynamics
2.3.1 Smart Drug Delivery Systems Industry Trends
2.3.2 Smart Drug Delivery Systems 麻豆原创 Drivers
2.3.3 Smart Drug Delivery Systems 麻豆原创 Challenges
2.3.4 Smart Drug Delivery Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Smart Drug Delivery Systems Players by Revenue
3.1.1 Global Top Smart Drug Delivery Systems Players by Revenue (2020-2025)
3.1.2 Global Smart Drug Delivery Systems Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Smart Drug Delivery Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Smart Drug Delivery Systems Revenue
3.4 Global Smart Drug Delivery Systems 麻豆原创 Concentration Ratio
3.4.1 Global Smart Drug Delivery Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Smart Drug Delivery Systems Revenue in 2024
3.5 Global Key Players of Smart Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Smart Drug Delivery Systems, Product and Application
3.7 Global Key Players of Smart Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Smart Drug Delivery Systems Breakdown Data by Type
4.1 Global Smart Drug Delivery Systems Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Smart Drug Delivery Systems Forecasted 麻豆原创 Size by Type (2026-2031)
5 Smart Drug Delivery Systems Breakdown Data by Application
5.1 Global Smart Drug Delivery Systems Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Smart Drug Delivery Systems Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Smart Drug Delivery Systems 麻豆原创 Size (2020-2031)
6.2 North America Smart Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Smart Drug Delivery Systems 麻豆原创 Size by Country (2020-2025)
6.4 North America Smart Drug Delivery Systems 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Smart Drug Delivery Systems 麻豆原创 Size (2020-2031)
7.2 Europe Smart Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Smart Drug Delivery Systems 麻豆原创 Size by Country (2020-2025)
7.4 Europe Smart Drug Delivery Systems 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Smart Drug Delivery Systems 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Smart Drug Delivery Systems 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Smart Drug Delivery Systems 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Smart Drug Delivery Systems 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Smart Drug Delivery Systems 麻豆原创 Size (2020-2031)
9.2 Latin America Smart Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Smart Drug Delivery Systems 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Smart Drug Delivery Systems 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Smart Drug Delivery Systems 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Smart Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Smart Drug Delivery Systems 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Smart Drug Delivery Systems 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Smart Drug Delivery Systems Introduction
11.1.4 Abbott Laboratories Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Adherium Ltd.
11.2.1 Adherium Ltd. Company Details
11.2.2 Adherium Ltd. Business Overview
11.2.3 Adherium Ltd. Smart Drug Delivery Systems Introduction
11.2.4 Adherium Ltd. Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.2.5 Adherium Ltd. Recent Development
11.3 Amiko Digital Health Limited
11.3.1 Amiko Digital Health Limited Company Details
11.3.2 Amiko Digital Health Limited Business Overview
11.3.3 Amiko Digital Health Limited Smart Drug Delivery Systems Introduction
11.3.4 Amiko Digital Health Limited Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.3.5 Amiko Digital Health Limited Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Details
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Smart Drug Delivery Systems Introduction
11.4.4 Becton, Dickinson and Company Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.4.5 Becton, Dickinson and Company Recent Development
11.5 BIOCORP
11.5.1 BIOCORP Company Details
11.5.2 BIOCORP Business Overview
11.5.3 BIOCORP Smart Drug Delivery Systems Introduction
11.5.4 BIOCORP Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.5.5 BIOCORP Recent Development
11.6 CeQur Corporation
11.6.1 CeQur Corporation Company Details
11.6.2 CeQur Corporation Business Overview
11.6.3 CeQur Corporation Smart Drug Delivery Systems Introduction
11.6.4 CeQur Corporation Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.6.5 CeQur Corporation Recent Development
11.7 Cognita Labs
11.7.1 Cognita Labs Company Details
11.7.2 Cognita Labs Business Overview
11.7.3 Cognita Labs Smart Drug Delivery Systems Introduction
11.7.4 Cognita Labs Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.7.5 Cognita Labs Recent Development
11.8 E3D Elcam Drug Delivery Devices
11.8.1 E3D Elcam Drug Delivery Devices Company Details
11.8.2 E3D Elcam Drug Delivery Devices Business Overview
11.8.3 E3D Elcam Drug Delivery Devices Smart Drug Delivery Systems Introduction
11.8.4 E3D Elcam Drug Delivery Devices Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.8.5 E3D Elcam Drug Delivery Devices Recent Development
11.9 H&T Presspart Manufacturing Ltd.
11.9.1 H&T Presspart Manufacturing Ltd. Company Details
11.9.2 H&T Presspart Manufacturing Ltd. Business Overview
11.9.3 H&T Presspart Manufacturing Ltd. Smart Drug Delivery Systems Introduction
11.9.4 H&T Presspart Manufacturing Ltd. Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.9.5 H&T Presspart Manufacturing Ltd. Recent Development
11.10 HCmed Innovations Co., Ltd.
11.10.1 HCmed Innovations Co., Ltd. Company Details
11.10.2 HCmed Innovations Co., Ltd. Business Overview
11.10.3 HCmed Innovations Co., Ltd. Smart Drug Delivery Systems Introduction
11.10.4 HCmed Innovations Co., Ltd. Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.10.5 HCmed Innovations Co., Ltd. Recent Development
11.11 Medtronic plc
11.11.1 Medtronic plc Company Details
11.11.2 Medtronic plc Business Overview
11.11.3 Medtronic plc Smart Drug Delivery Systems Introduction
11.11.4 Medtronic plc Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.11.5 Medtronic plc Recent Development
11.12 Novo Nordisk A/S
11.12.1 Novo Nordisk A/S Company Details
11.12.2 Novo Nordisk A/S Business Overview
11.12.3 Novo Nordisk A/S Smart Drug Delivery Systems Introduction
11.12.4 Novo Nordisk A/S Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.12.5 Novo Nordisk A/S Recent Development
11.13 Phillips-Medisize
11.13.1 Phillips-Medisize Company Details
11.13.2 Phillips-Medisize Business Overview
11.13.3 Phillips-Medisize Smart Drug Delivery Systems Introduction
11.13.4 Phillips-Medisize Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.13.5 Phillips-Medisize Recent Development
11.14 Sonceboz
11.14.1 Sonceboz Company Details
11.14.2 Sonceboz Business Overview
11.14.3 Sonceboz Smart Drug Delivery Systems Introduction
11.14.4 Sonceboz Revenue in Smart Drug Delivery Systems Business (2020-2025)
11.14.5 Sonceboz Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Adherium Ltd.
Amiko Digital Health Limited
Becton, Dickinson and Company
BIOCORP
CeQur Corporation
Cognita Labs
E3D Elcam Drug Delivery Devices
H&T Presspart Manufacturing Ltd.
HCmed Innovations Co., Ltd.
Medtronic plc
Novo Nordisk A/S
Phillips-Medisize
Sonceboz

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.